Baillie Gifford & CO Charles River Laboratories International, Inc. Transaction History

Baillie Gifford & CO

$127 Billion
Q4 2024

A detailed history of Baillie Gifford & CO transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Baillie Gifford & CO holds 75,411 shares of CRL stock, worth $12.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

75,411

Previous 68,585 9.95%

Holding current value

$12.5 Million

Previous $13.5 Million 3.03%

% of portfolio

0.01%

Previous 0.01%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 31, 2025	BUY	$178.58 - $220.69 $1.22 Million - $1.51 Million	6,826 Added 9.95%	75,411 $13.9 Million
Q3 2024 Nov 05, 2024	BUY	$187.96 - $245.29 $196,982 - $257,063	1,048 Added 1.55%	68,585 $13.5 Million
Q2 2024 Jul 25, 2024	BUY	$206.39 - $268.73 $619 - $806	3 Added 0.0%	67,537 $14 Million
Q1 2024 May 01, 2024	SELL	$203.52 - $273.43 $542,991 - $729,511	-2,668 Reduced 3.8%	67,534 $18.3 Million
Q4 2023 Jan 26, 2024	SELL	$164.52 - $238.84 $1.54 Million - $2.24 Million	-9,370 Reduced 11.78%	70,202 $16.6 Million
Q3 2023 Nov 13, 2023	SELL	$194.44 - $217.61 $1.07 Million - $1.2 Million	-5,524 Reduced 6.49%	79,572 $15.6 Million
Q2 2023 Jul 28, 2023	SELL	$183.71 - $210.25 $72,381 - $82,838	-394 Reduced 0.46%	85,096 $17.9 Million
Q1 2023 May 03, 2023	BUY	$191.89 - $259.92 $2.71 Million - $3.67 Million	14,118 Added 19.78%	85,490 $17.3 Million
Q4 2022 Jan 24, 2023	SELL	$197.11 - $250.07 $103,876 - $131,786	-527 Reduced 0.73%	71,372 $15.6 Million
Q3 2022 Oct 27, 2022	BUY	$182.44 - $250.54 $10.2 Million - $14.1 Million	56,103 Added 355.17%	71,899 $14.2 Million
Q2 2022 Aug 08, 2022	BUY	$204.13 - $302.4 $3.22 Million - $4.78 Million	15,796 New	15,796 $3.38 Million

Others Institutions Holding CRL

# of Institutions

710

Shares Held

53.9M

Call Options Held

122K

Put Options Held

239K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.41B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baillie Gifford & CO, based on Form 13F filings with the SEC.

News

Stay updated on Baillie Gifford & CO with notifications on news.

Account

Baillie Gifford & CO Charles River Laboratories International, Inc. Transaction History